Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).
Sassaki LY, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, De Abreu Ferrari ML, Zacharias P, Feitosa MR, Dos Santos CHM, De Freitas Lins Neto MA, Quaresma AB, De Lima Junior SF, De Vasconcelos GBS, Cassol OS, Dos Santos Pinto A, Kurachi G, Goncalves Filho FA, Gasparini RG, Furlan TK, Catapani WR, Coy CSR, De Souza Menegassi V, Colombo MM, Fróes RSB, Teixeira FV, Moraes AC, Santana GO, Parente JML, Vilela EG, Queiroz NSF, Kotze PG; GEDIIB (Brazilian Study Group of IBD). Sassaki LY, et al. Among authors: queiroz nsf. BMC Gastroenterol. 2022 May 29;22(1):268. doi: 10.1186/s12876-022-02341-7. BMC Gastroenterol. 2022. PMID: 35644668 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33656063
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey.
Queiroz NSF, Teixeira FV, Motta MP, Chebli LA, Hino AAF, Martins CA, Quaresma AB, da Silva AAP, Damião AOMC, Saad-Hossne R, Kotze PG. Queiroz NSF, et al. World J Gastroenterol. 2021 Mar 28;27(12):1226-1239. doi: 10.3748/wjg.v27.i12.1226. World J Gastroenterol. 2021. PMID: 33828396 Free PMC article.
BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.
Queiroz NSF, Teixeira FV, Freire CCF, Motta MP, Vasconcellos MAM, Chebli LA, Saad-Hossne R; Brazilian Inflamatory Bowel Diseases Study Group (GEDIIB) COVID taskforce. Queiroz NSF, et al. Arq Gastroenterol. 2021 Jan-Mar;58(1):1-4. doi: 10.1590/S0004-2803.202100000-02. Arq Gastroenterol. 2021. PMID: 33909805 Free article.
Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients.
Garcia KS, Facas BP, Machado MB, Teixeira FV, Avedano L, Lönnfors S, Hossne RS, Peyrin-Biroulet L, Queiroz NSF. Garcia KS, et al. Among authors: queiroz nsf. Therap Adv Gastroenterol. 2021 May 18;14:17562848211013249. doi: 10.1177/17562848211013249. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34046083 Free PMC article.
Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB).
Romero RK, Magro DO, Queiroz NSF, Damião AOMC, Teixeira FV, Nones RB, Sassaki LY, Saad-Hossne R, Kotze PG. Romero RK, et al. Among authors: queiroz nsf. Gastroenterol Hepatol. 2022 Aug-Sep;45(7):499-506. doi: 10.1016/j.gastrohep.2021.09.005. Epub 2021 Oct 8. Gastroenterol Hepatol. 2022. PMID: 34634427 English, Spanish.
44 results